Denagard 10
This page contains information on Denagard 10 for veterinary use.The information provided typically includes the following:
- Denagard 10 Indications
- Warnings and cautions for Denagard 10
- Direction and dosage information for Denagard 10
Denagard 10
This treatment applies to the following species:(tiamulin hydrogen fumarate)
Type B Medicated Swine Feed
Active Ingredient
Tiamulin hydrogen fumarate: 10 g/lb
GUARANTEED ANALYSIS
Crude Fat, not less than |
4% |
Crude Fiber, not more than |
50% |
Crude Protein, not less than |
1% |
Ingredients: rice hulls, mineral oil, porcine gelatin
For Manufacture of Type C medicated swine feed only.
Do not feed undiluted.
Denagard 10 Indications |
Amount of Type B Medicated Feed Per Ton of Feed |
Tiamulin hydrogen fumarate in Complete Type C Medicated Feed Per Ton |
Withdrawal Period |
For treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin |
20 lb |
200 g |
7 |
For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis |
3.5 lb |
35 g |
2 |
For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin |
3.5 lb |
35 g |
2 |
Warnings
![]() |
Observe withdrawal time shown in table above. |
![]() |
Keep out of reach of children. Avoid contact with skin. Direct contact with skin or mucous membranes may cause irritation.
Denagard 10 Caution
Do not feed undiluted. Do not use in feeds for animals other than swine. The effects of tiamulin on swine reproductive performance, pregnancy and lactation have not been determined. Swine being treated with Denagard (tiamulin) should not have access to feeds containing polyether ionophores (e.g., lasalocid, monensin, narasin, salinomycin and semduramicin) as adverse reactions may occur. If signs of toxicity occur, discontinue use.
Mixing Directions
Mix this medicated feed (Type B) with non-medicated feed ingredients to make a Type C medicated feed as follows:
Type C Medicated Feed Tiamulin grams/ton Feed |
Pounds Medicated Feed (Type B) |
Pounds Non-medicated Feed* |
35 |
3.5 |
1996.5 |
200 |
20 |
1980 |
*When making an approved Type C medicated feed drug combination, the inclusion rate of this non-medicated feed should be adjusted for the amount of the other drug added to make such combination Type C medicated feed.
Storage
Store at or below 25°C (77°F). Temporary excursions to 40°C (104°F) permitted.
To report adverse effects, access medical information, or obtain additional product information call 1-800-428-4441
For a complete listing of adverse reactions for DENAGARD reported to CVM see:
www.fda.gov/reportanimalae
Denagard, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Restricted Drug (California): Use only as directed.
Approved by FDA under NADA # 139-472
Marketed by: Elanco US, Inc., Greenfield, IN 46140
Net Weight: |
|
35 lb (15.9 kg) |
BG101792X |
CPN: 1114102.6
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service: | 317-276-1262 | |
Technical Service: | 800-428-4441 | |
Website: | www.elanco.us | |
Email: | elanco@elanco.com |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. |
Copyright © 2023 Animalytix LLC. Updated: 2023-11-27